Associate Professor James McGree is a Chief Investigator on the recently announced Australian Government’s Medical Research Future Fund (MRFF) for coronavirus-related research. The project team is led out of the University of New South Wales by Associate Professor Meg Jardine and will work on “Repurposing existing medications to reduce severe acute respiratory distress in patients with COVID-19: the CLARITY trial”. It will examine whether Angiotensin Receptor Blockers (ARBs) – a widely-used blood pressure medication – can shorten the duration of severe COVID-19 disease and reduce the risk of developing severe disease in high-risk SARS-CoV-2-positive patients.
